Subscribe
Tuesday, September 15, 2026
21.6 C
Bengaluru
type here...
Subscribe
Featured ArticleIndian Pharma Market Reports
4 min.Read

IPM February 2026: Market Intelligence Report

Anup Soans
By Anup Soans

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth trajectory in early 2026, recording 11.0% year-on-year (YoY) growth in February 2026, with monthly sales reaching ₹20,836 crore. The Moving Annual Total (MAT) stood at ₹2,44,277 crore, reflecting 8.4% annual growth. Growth remained broad-based across all three levers—price (+5.3%), new product introductions (+3.5%), and volume…

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...

Topics

MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...
MedicinMan Pharma Pulse

MedicinMan Pharma Pulse: August 2026

0
🚀 The Mega-Merger That Wasn't Early August saw the...
Featured Article

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

0
STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...
Exclusive Report

How To See Dr Reddy’s Nestle In The Wellness Shift

0
GLP-1 medicines such as semaglutide and tirzepatide are changing...
spot_img

Related Articles

spot_imgspot_img
Previous article
FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare
Next article
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk